Personalized Medicine and Novel Therapy

About Conference

We invite the participants from all over the world for the “14th World Congress on Personalized Medicine and Novel Therapy” which is going to be held on December 07-08, 2022 at Singapore City, Singapore. Conference Series is a world’s foremost event Organizer conducting International conferences in USA, Europe, Asia-Pacific and Middle East.

Personalized Medicine 2022 highlights the theme “Exploring Innovations and Knowledge of Personalized Medicine”. This will broadly cover the fields of Personalized Medicine as well as for initiation of new prospects and to explore new tendencies in the field of Personalized Medicine.

Why to attend?

The Personalized medicine 2022 will enlighten the world with recent advances in Personalized medicine and Novel research and inculcate new ideas about Novel health. Moreover, this Personalized medicine Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the Personalized medicine. Fields are the unique attributes of this conference. Personalized medicine symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Personalized medicine and Novel Therapies.

Our aim is to aggregate community and to create a platform for exchange of information on technological developments, new scientific innovations and the effectiveness of various regulatory programs towards Personalized medicine 2022. It provides a premier technical forum for expressing and knowledge about the advanced research and developments, as well as exploration of new applications, technologies and to explore new trends in the field of Personalized medicine.

Scientific Sessions

Session 01: Personalized medicine

Personalized medicine, precision medicine, or theranostics is a medical model that separates people into different groups with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept[1][2] though some authors and organisations use these expressions separately to indicate particular nuances.

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Session 02: Personalized medicine to heart

Research on cardiovascular genetics has had some spectacular successes in uncovering new therapeutic targets—for example, the finding that people with inactivating mutations in the gene encoding the trafficking protein PCSK9 are at a much lower risk for heart attacks led to the development of antibody therapy targeting this protein. However, when it comes to personalizing treatment for cardiovascular disease on the basis of an individual patient's genetic makeup or biomarker data, there are currently only a handful of options where such an approach has proven to be clinically useful.

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Session 03: Personalized Immunotherapy

There are currently three major approaches to T cell-based cancer immunotherapy, namely, active vaccination, adoptive cell transfer therapy and immune checkpoint blockade. Recently, this latter approach has demonstrated remarkable clinical benefits, putting cancer immunotherapy under the spotlight. Better understanding of the dynamics of anti-tumour immune responses (the "Cancer-Immunity Cycle") is crucial for the further development of this form of treatment. 

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Session 04: Personalized medicine: Drug discovery and patient care.

Advances in human genome research are opening the door to a new paradigm for practising medicine that promises to transform healthcare. Personalized medicine, the use of marker-assisted diagnosis and targeted therapies derived from an individual's molecular profile, will impact the way drugs are developed and medicine is practiced. 

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Session 05: Individualized Treatment through Personalized Medicine

This perspective addresses conceptual approaches that can be undertaken to develop and apply clinical decision support in electronic health record systems to achieve personalized medical care. In addition, to represent meaningful benefits to personalized decision-making, a comparison of current and future applications of clinical decision support to enable individualized medical treatment plans is presented. 

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Session 06 : Personalized Medicine in Oncology

The development of cost-effective technologies able to comprehensively assess DNA, RNA, protein, and metabolites in patient tumours has fuelled efforts to tailor medical care. Indeed validated molecular tests assessing tumour tissue or patient germ line DNA already drive therapeutic decision making. However, many theoretical and regulatory challenges must still be overcome before fully realizing the promise of personalized molecular medicine.

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Session 07: Pharmacogenomics & Personalized Medicine

The vision of personalized medicine, the practice of medicine where each patient receives the most appropriate medical treatments and the most fitting dosage and combination of drugs based on his or her genetic make-up, seems to become more realistic as our knowledge about the human genome rapidly expands. We already know the reason for many types of adverse drug reactions, which are often related to polymorphic gene alleles of drug metabolizing enzymes. 

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Session 08 : Metabolomics in Personalized medicine

The ability of biomarkers to improve treatment and reduce healthcare costs is potentially greater than in any other area of current medical research. For example, the American Society of Clinical Oncology estimates that routinely testing people with colon cancer for mutations in the K-RAS oncogene would save at least US $600 million a years. 

Related Subjects : Precision Medicine, Genetics, Genomics, Precision Medicine, Novel Treatment, Proteomics and Genomics, Family Medicine, Ortho Medicine, Emergency medicine, Public Health

Market Analysis

The Euro market estimation for customized drugs is anticipated to develop at the exacerbated yearly development rate of 7.5% amid 2009 to 2015. This development in future is required to be driven by various elements such as cost investment funds on medicines, early conclusion of ailment, medication wellbeing, quiet consistence, and improvement of treatments. Right now, America commands the business sector for customized pharmaceutical; be that as it may, progression in innovation and advancements in the field of DNA is required to set up Personalized Medicine Market in USA, UK, France, India, China, and Japan.

Quick advances in innovation have made it attainable to recognize a man's one of a kind genome. One individual varies from another by a large number of varieties in the genome, and a considerable lot of these varieties influence weakness to infection and reaction to medications. More noteworthy comprehension of individual genomes is permitting researchers and clinicians to start to "customize" medication. The Personalized Genomic Medicine insurgency will yield more viable medications with less unfavourable reactions and lead to longer, more beneficial lives and lower human services costs. The customized pharmaceutical industry in the United States as of now produces $286 billion every year in incomes and is developing by 11% every year, as indicated by Price water house Coopers Research at JAX Genomic Medicine will add to customized solution by uncovering how genomic varieties influence wellbeing, malady and medication reaction.
The worldwide Personalized Medicine Industry was esteemed at 8,956.14 billion EUR in 2014 and is relied upon to achieve 2179.32 billion EUR in 2022, developing at a CAGR of 11.8% over the gauge period. Key drivers of the business sector incorporate developing improvement of cutting edge sequencing, entire genome innovation, partner diagnostics and developing number of retail facilities.

Targeted audience

• Psychiatrist
• Cardiologists
• Oncologists
• Physiotherapists
• Cancer therapy Institutes
• Endocrinologist
• Neurologist
• Nephrologist
• Scientists
• Directors/Managers
• Presidents & Vice Presidents/ Directors / Administrators
• Business Entrepreneurs
• COPD Associations/ Societies
• Young Researchers
• Medical Students
• Nurses
• Medical Devices Companies
• Palliative care Doctors/Nurses

Past Conference Reports

Personalised Medicine 2021

Conference series LLC Ltd, hosted the “14th World Congress on Personalized Medicine and Novel Therapy” to be held in  during December 03-04, 2021 at Singapore city, Singapore. Which based on the theme “Exploring Innovations and Knowledge of Personalized Medicine" It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering. The adepts who promulgated the theme with their exquisite talks were: Lejla R. Stojanovic (Serbia), Alexandre De Luca (Argentina), Florian FORELLI(France),MaudeTRAULLE(France). Scientific sessions discussed during Conference are about Personalized medicine for Diabetes, Personalized Medicine in Oncology, Treatment of Genetic Disorders, Precision Medicine and Novel Technology, Noval Therapy in Hospice, Aging and Geriatrics

Personalized Medicine 2020

Conference series LLC Ltd, hosted the “Personalized Medicine and Novel Therapy” held on May 13, 2020 at Berlin, Germany. but due to the pandemic situation it is organized as webinar. We would like to thank all of our wonderful Keynotes, Speakers, and Students for making Personalized Medicine 2020 Webinar a successful online event. The adepts who promulgated the theme with their exquisite talks were: Vania Assaly (Brazil), Alexandre De Luca (Argentina), Winston Vo (USA), Rauph GuimAraes (Brazil). Scientific sessions discussed during Conference are about Personalized Palliative care, Drug Target Discovery and Integration, Personalized Biological Therapies, Treatment of Genetic Disorders, Personalized Medicine in Oncology

Personalized Medicine 2019

Conference series LLC Ltd, hosted the “11th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics” to be held in  during October 30-31, 2019 at Vancouver, Canada. Which based on the theme “Exploring the New Era of individualized treatment through science, Technology and Personalized Medicine" It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering. The adepts who promulgated the theme with their exquisite talks were: Deirdre Kelly (Ireland), Adrian Llerena (Spain), Hiroyuki A. Watanabe (Japan), Andreas Scherer(USA) Scientific sessions discussed during Conference are about Paths Of Biomarkers, Life Style Medicine, Preventive Medicines,  Personalized oncology Personalized, Drug Therapy

Personalized Medicine 2018

Conference series LLC Ltd, hosted the “9th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics” to be held in  during October 26-27, 2018 at Bostan, USA. Which based on the theme “Innovations & Advances in the field of Personalized Medicine and Molecular Diagnostics" It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering. The adepts who promulgated the theme with their exquisite talks were: Ramón Cacabelos (Spain), Óscar Teijido (Spain), Maria Voyatzi (Greece), Roland Valdes (USA) Scientific sessions discussed during Conference are about Immunology infectious disease, Psychotherapy, Treatment of Genetic Disorders,  Ethics of personalized medicine,  Precision Medicine and Personalized Medicine

Personalized Medicine 2017

Conference series LLC Ltd, hosted the “7th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics” to be held in  during October 05-06, 2017 at Chicago, USA. Which based on the theme “Comprehensive Overview of What Personalized Medicine Means Today" It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering. The adepts who promulgated the theme with their exquisite talks were: K. K. Jain (Switzerland), Mark R. Miglarese (USA), Michael Szardenings (Germany), Steven A. Feyrer-Melk (USA) Scientific sessions discussed during Conference are about Cardiology and vascular medicine Personalized oncology, Advances In Molecular Diagnostics, Approaches To Stem Cells, Nanotechnology, Future Of Personalised Medicine